Microparticles in cardiovascular diseases

Cardiovascular Research

Volumn 59, Issue 2, 2003, Pages 277-287

  VanWijk, Marja J ^a   VanBavel, E ^a   Sturk, A ^a   Nieuwland, R ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Coronary disease; Endothelial function; Hemostasis; Platelets; Thrombosis

Indexed keywords

ABCIXIMAB; ASCORBIC ACID; CALCIUM; FIBRINOGEN RECEPTOR; FIBRINOGEN RECEPTOR ANTAGONIST; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PADGEM PROTEIN; THROMBOPLASTIN;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTERY MUSCLE; BLEEDING TENDENCY; CALCIUM BLOOD LEVEL; CARDIOVASCULAR DISEASE; CELL ACTIVATION; CELL MEMBRANE; CELL SIZE; CONGESTIVE HEART FAILURE; CYTOKINE RELEASE; DIABETES MELLITUS; DISEASE CLASSIFICATION; ENDOTHELIUM CELL; GLANZMANN DISEASE; HEART MUSCLE ISCHEMIA; HUMAN; HYPERCOAGULABILITY; HYPERTENSION; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LIVER CELL; MEMBRANE VESICLE; MICROPARTICLE; MONONUCLEAR CELL; OXIDATIVE STRESS; PAROXYSMAL DYSPNEA; PATHOPHYSIOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHOSPHOLIPID BILAYER; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; REVIEW; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOCYTE ACTIVATION; THROMBOCYTE MEMBRANE; UREMIA;

ANTIBODIES, MONOCLONAL; ANTICOAGULANTS; ANTIOXIDANTS; APOPTOSIS; ASCORBIC ACID; BLOOD COAGULATION; BLOOD PLATELETS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; INFLAMMATION; LIPID METABOLISM; MALE; MEMBRANE LIPIDS; PLATELET ACTIVATION; SUBCELLULAR FRACTIONS;

EID: 0142122248     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(03)00367-5     Document Type: Review

References (92)

1. Wolf P. The nature and significance of platelet products in human plasma. Br. J. Haematol. 13:(3):1967;269-288.
2. Forlow S.B., McEver R.P., Nollert M.U. Leukocyte-leukocyte interactions mediated by platelet microparticles under flow. Blood. 95:(4):2000;1317-1323.
3. Sims P.J., Wiedmer T., Esmon C.T., Weiss H.J., Shattil S.J. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J. Biol. Chem. 264:(29):1989;17049-17057.
4. Tans G., Rosing J., Thomassen M.C., et al. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. Blood. 77:(12):1991;2641-2648.
5. Taube J., McWilliam N., Luddington R., Byrne C.D., Baglin T. Activated protein C resistance: effect of platelet activation, platelet-derived microparticles, and atherogenic lipoproteins. Blood. 93:(11):1999;3792-3797.
6. Barry O.P., Pratico D., Lawson J.A., Fitzgerald G.A. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J. Clin. Invest. 99:(9):1997;2118-2127.
7. Gilbert G.E., Sims P.J., Wiedmer T., et al. Platelet-derived microparticles express high affinity receptors for factor VIII. J. Biol. Chem. 266:(26):1991;17261-17268.
8. Siljander P., Carpen O., Lassila R. Platelet-derived microparticles associate with fibrin during thrombosis. Blood. 87:(11):1996;4651-4663.
9. Gemmell C.H., Sefton M.V., Yeo E.L. Platelet-derived microparticle formation involves glycoprotein IIb-IIIa. Inhibition by RGDS and a Glanzmann's thrombasthenia defect. J. Biol. Chem. 268:(20):1993;14586-14589.
10. Wiedmer T., Sims P.J. Participation of protein kinases in complement C5b-9-induced shedding of platelet plasma membrane vesicles. Blood. 78:(11):1991;2880-2886.
11. Sims P.J., Faioni E.M., Wiedmer T., Shattil S.J. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J. Biol. Chem. 263:(34):1988;18205-18212.
12. Miyazaki Y., Nomura S., Miyake T., et al. High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood. 88:(9):1996;3456-3464.
13. Holme P.A., Orvim U., Hamers M.J., et al. Shear-induced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis. Arterioscler. Thromb. Vasc. Biol. 17:(4):1997;646-653.
14. Fourcade O., Simon M.F., Viode C., et al. Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell. 80:(6):1995;919-927.
15. Satta N., Toti F., Feugeas O., et al. Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. J. Immunol. 153:(7):1994;3245-3255.
16. Combes V., Simon A.C., Grau G.E., et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J. Clin. Invest. 104:(1):1999;93-102.
17. Patel K.D., Zimmerman G.A., Prescott S.M., McIntyre T.M. Novel leukocyte agonists are released by endothelial cells exposed to peroxide. J. Biol. Chem. 267:(21):1992;15168-15175.
18. Miyoshi H., Umeshita K., Sakon M., et al. Calpain activation in plasma membrane bleb formation during tert-butyl hydroperoxide-induced rat hepatocyte injury. Gastroenterology. 110:(6):1996;1897-1904.
19. Leeuwenberg J.F., Smeets E.F., Neefjes J.J., et al. E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro. Immunology. 77:(4):1992;543-549.
20. Schecter A.D., Spim B., Rossikhina M., et al. Release of active tissue factor by human arterial smooth muscle cells. Circ. Res. 87:(2):2000;126-132.
21. Huber J., Vales A., Mitulovic G., et al. Oxidized membrane vesicles and blebs from apoptotic cells contain biologically active oxidized phospholipids that induce monocyte-endothelial interactions. Arterioscler. Thromb. Vasc. Biol. 22:(1):2002;101-107.
22. Ariyoshi H., Salzman E.W. Association of localized Ca2+ gradients with redistribution of glycoprotein IIb-IIIa and F-actin in activated human blood platelets. Arterioscler. Thromb. Vasc. Biol. 16:(2):1996;230-235.
23. Coleman M.L., Sahai E.A., Yeo M., et al. Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. Nat. Cell Biol. 3:(4):2001;339-345.
24. Yano Y., Kambayashi J., Shiba E., et al. The role of protein phosphorylation and cytoskeletal reorganization in microparticle formation from the platelet plasma membrane. Biochem. J. 299:(Pt 1):1994;303-308.
25. Fox J.E., Austin C.D., Boyles J.K., Steffen P.K. Role of the membrane skeleton in preventing the shedding of procoagulant-rich microvesicles from the platelet plasma membrane. J. Cell Biol. 111:(2):1990;483-493.
26. Basse F., Gaffet P., Bienvenue A. Correlation between inhibition of cytoskeleton proteolysis and anti-vesiculation effect of calpeptin during A23187-induced activation of human platelets: are vesicles shed by filopod fragmentation? Biochim. Biophys. Acta. 1190:(2):1994;217-224.
27. Fox J.E. The platelet cytoskeleton. Thromb. Haemost. 70:(6):1993;884-893.
28. Mallat Z., Tedgui A. Current perspective on the role of apoptosis in atherothrombotic disease. Circ. Res. 88:(10):2001;998-1003.
29. Cotter T.G., Lennon S.V., Glynn J.M., Green D.R. Microfilament-disrupting agents prevent the formation of apoptotic bodies in tumor cells undergoing apoptosis. Cancer Res. 52:(4):1992;997-1005.
30. Mills J.C., Stone N.L., Erhardt J., Pittman R.N. Apoptotic membrane blebbing is regulated by myosin light chain phosphorylation. J. Cell Biol. 140:(3):1998;627-636.
31. Maekawa M., Ishizaki T., Boku S., et al. Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science. 285:(5429):1999;895-898.
32. Zwaal R.A., Schroit A.J. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood. 89:(4):1997;1121-1132.
33. Pitney W.R., Dacie J.V. A simple method of studying the generation of thrombin in recalcified plasma. J. Clin. Pathol. 6:1953;9.
34. Weerheim A.M., Kolb A.M., Sturk A., Nieuwland R. Phospholipid composition of cell-derived microparticles determined by one-dimensional high-performance thin-layer chromatography. Anal. Biochem. 302:(2):2002;191-198.
35. Berckmans R.J., Nieuwland R., Boing A.N., et al. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb. Haemost. 85:(4):2001;639-646.
36. Berckmans R.J., Nieuwland R., Tak P.P., Boing A.N., Romijn F.P., Kraan M., Breedveld F.C., Hack C.E., Sturk A. Cell-derived microparticles from synovial fluid of inflamed arthritic joints support coagulation exclusively via a factor VII-dependent mechanism. Arthritis Rheum. 46:(11):2002;2857-2866.
37. Aupeix K., Hugel B., Martin T., et al. The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection. J. Clin. Invest. 99:(7):1997;1546-1554.
38. Blanchard N., Lankar D., Faure F., et al. TCR activation of human T cells induces the production of exosomes bearing the TCR/CD3/zeta complex. J. Immunol. 168:(7):2002;3235-3241.
39. Salzer U., Hinterdorfer P., Hunger U., Borken C., Prohaska R. Ca(++)-dependent vesicle release from erythrocytes involves stomatin-specific lipid rafts, synexin (annexin VII), and sorcin. Blood. 99:(7):2002;2569-2577.
40. Butikofer P., Kuypers F.A., Xu C.M., Chiu D.T., Lubin B. Enrichment of two glycosyl-phosphatidylinositol-anchored proteins, acetylcholinesterase and decay accelerating factor, in vesicles released from human red blood cells. Blood. 74:(5):1989;1481-1485.
41. Pascual M., Lutz H.U., Steiger G., Stammler P., Schifferli J.A. Release of vesicles enriched in complement receptor 1 from human erythrocytes. J. Immunol. 151:(1):1993;397-404.
42. Hughes M., Hayward C.P.M., Warkentin T.E., et al. Morphological analysis of microparticle generation in heparin-induced thrombocytopenia. Blood. 96:(1):2000;188-194.
43. VanWijk M.J., Nieuwland R., Boer K., et al. Microparticle subpopulations are increased in pre-eclampsia: possible involvement in vascular dysfunction? Am. J. Obstet. Gynecol. 187:2002;450-456.
44. Issekutz T.B., Issekutz A.C., Movat H.Z. The in vivo quantitation and kinetics of monocyte migration into acute inflammatory tissue. Am. J. Pathol. 103:(1):1981;47-55.
45. Barry O.P., Pratico D., Savani R.C., Fitzgerald G.A. Modulation of monocyte-endothelial cell interactions by platelet microparticles. J. Clin. Invest. 102:(1):1998;136-144.
46. Mesri M., Altieri D.C. Endothelial cell activation by leukocyte microparticles. J. Immunol. 161:(8):1998;4382-4387.
47. Nomura S., Tandon N.N., Nakamura T., et al. High-shear-stress-induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cells. Atherosclerosis. 158:(2):2001;277-287.
48. Mesri M., Altieri D.C. Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signaling pathway. J. Biol. Chem. 274:(33):1999;23111-23118.
49. Zamzami N., Marchetti P., Castedo M., et al. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 182:1995;367-377.
50. Witztum J.L., Steinberg D. The oxidative modification hypothesis of atherosclerosis: does it hold for humans? Trends Cardiovasc. Med. 11:(3-4):2001;93-102.
51. Freyssinet J.M., Toti F., Hugel B., et al. Apoptosis in vascular disease. Thromb. Haemost. 82:(2):1999;727-735.
52. Buemi M., Allegra A., D'Anna R., et al. Is apoptosis cause of pre-eclampsia? Eur. Rev. Med. Pharmacol. Sci. 2:(5-6):1998;185-188.
53. Boullier A., Bird D.A., Chang M.K., et al. Scavenger receptors, oxidized LDL, and atherosclerosis. Ann. N Y Acad. Sci. 947:2001;214-223.
54. Smiley P.L., Stremler K.E., Prescott S.M., Zimmerman G.A., McIntyre T.M. Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor. J. Biol. Chem. 266:(17):1991; 11104-11110.
55. Lorant D.E., Zimmerman G.A., McIntyre T.M., Prescott S.M. Platelet-activating factor mediates procoagulant activity on the surface of endothelial cells by promoting leukocyte adhesion. Semin. Cell Biol. 6:(5):1995;295-303.
56. Gerard N.P., Gerard C. Receptor-dependent internalization of platelet-activating factor. J. Immunol. 152:(2):1994;793-800.
57. Chao W., Olson M.S. Platelet-activating factor: receptors and signal transduction. Biochem. J. 292:(Pt 3):1993;617-629.
58. Becker R.C. Anticoagulation and the heart. J. Thromb. Thrombolysis. 12:(1):2001;41-52.
59. Hamilton K.K., Hattori R., Esmon C.T., Sims P.J. Complement proteins C5b-9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex. J. Biol. Chem. 265:(7):1990;3809-3814.
60. Joop K., Berckmans R.J., Nieuwland R., et al. Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms. Thromb. Haemost. 85:(5):2001;810-820.
61. VanWijk M.J., Boer K., Berckmans R.J., et al. Enhanced coagulation activation in pre-eclampsia: the role of APC resistance, microparticles and other plasma constituents. Thromb. Haemost. 88:2002;415-420.
62. Shimura M., Wada H., Wakita Y., et al. Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation. Am. J. Hematol. 52:(3):1996;165-170.
63. Nieuwland R., Berckmans R.J., Rotteveel-Eijkman R.C., et al. Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant. Circulation. 96:(10):1997;3534-3541.
64. Nieuwland R., Berckmans R.J., McGregor S., et al. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood. 95:(3):2000;930-935.
65. Taylor F.B. Jr., He S.E., Chang A.C., et al. Infusion of phospholipid vesicles amplifies the local thrombotic response to TNF and anti-protein C into a consumptive response. Thromb. Haemost. 75:(4):1996;578-584.
66. Sugimura M., Kobayashi T., Shu F., Kanayama N., Terao T. Annexin V inhibits phosphatidylserine-induced intrauterine growth restriction in mice. Placenta. 20:(7):1999;555-560.
67. Celi A., Pellegrini G., Lorenzet R., et al. P-selectin induces the expression of tissue factor on monocytes. Proc. Natl. Acad. Sci. U.S.A. 91:(19):1994;8767-8771.
68. Castaman G., Yu-Feng L., Battistin E., Rodeghiero F. Characterization of a novel bleeding disorder with isolated prolonged bleeding time and deficiency of platelet microvesicle generation. Br. J. Haematol. 96:(3):1997;458-463.
69. Fang Z.Y., Marwick T.H. Vascular dysfunction and heart failure: epiphenomenon or etiologic agent? Am. Heart. J. 143:(3):2002;383-390.
70. Neunteufl T., Katzenschlager R., Hassan A., et al. Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease. Atherosclerosis. 129:(1):1997;111-118.
71. Liao J.K. Endothelium and acute coronary syndromes. Clin. Chem. 44:(8 Pt 2):1998;1799-1808.
72. Contreras F., Rivera M., Vasquez J., De la Parte M.A., Velasco M. Endothelial dysfunction in arterial hypertension. J. Hum. Hypertens. 14:(Suppl. 1):2000;S20-S25.
73. Roberts J.M. Endothelial dysfunction in pre-eclampsia. Semin. Reprod. Endocrinol. 16:(1):1998;5-15.
74. Boulanger C.M., Scoazec A., Ebrahimian T., et al. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation. 104:(22):2001;2649-2652.
75. VanWijk M.J., Svedas E., Boer K., Nieuwland R., VanBavel E., Kublickiene K.R. Isolated microparticles, but not whole plasma, from women with pre-eclampsia impair endothelium-dependent relaxation in isolated myometrial arteries from normal pregnant women. Am J Obstet Gynecol. 187:(6):2002; 1686-1693.
76. Mallat Z., Hugel B., Ohan J., et al. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation. 99:(3):1999;348-353.
77. Rikitake Y., Hirata K., Kawashima S., et al. Inhibition of endothelium-dependent arterial relaxation by oxidized phosphatidylcholine. Atherosclerosis. 152:(1):2000;79-87.
78. Nomura S., Imamura A., Okuno M., et al. Platelet-derived microparticles in patients with arteriosclerosis obliterans. Enhancement of high shear-induced microparticle generation by cytokines. Thromb. Res. 98:(4):2000;257-268.
79. Bizios R., Lai L.C., Cooper J.A., Del Vecchio P.J., Mailk A.B. Thrombin-induced adherence of neutrophils to cultured endothelial monolayers: increased endothelial adhesiveness. J. Cell. Physiol. 134:(2):1988;275-280.
80. Reverter J.C., Beguin S., Kessels H., et al. Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and 'clinical restenosis'. J. Clin. Invest. 98:(3):1996;863-874.
81. Lee Y.J., Jy W., Horstman L.L., et al. Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multi-infarct dementias. Thromb. Res. 72:(4):1993;295-304.
82. Rossig L., Hoffmann J., Hugel B., et al. Vitamin C inhibits endothelial cell apoptosis in congestive heart failure. Circulation. 104:(18):2001; 2182-2187.
83. Jy W., Mao W.W., Horstman L.L., Tao J., Ahn Y.S. Platelet microparticles bind, activate and aggregate neutrophils in vitro. Blood Cells Mol. Dis. 21:(3):1995;217-231.
84. Mack M., Kleinschmidt A., Bruhl H., et al. Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection. Nat. Med. 6:(7):2000;769-775.
85. Tate D.A., Bode A.P., Nichols T.C., Dehmer G.J. Platelet activation detected by platelet-derived microparticles in coronary sinus blood from patients with unstable coronary syndromes. Circulation. 86:1992;3193A.
86. Mallat Z., Benamer H., Hugel B., et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation. 101:(8):1999;841-843.
87. Nomura S., Komiyama Y., Miyake T., et al. Amyloid beta-protein precursor-rich platelet microparticles in thrombotic disease. Thromb. Haemost. 72:(4):1994;519-522.
88. Nomura S., Suzuki M., Katsura K., et al. Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus. Atherosclerosis. 116:(2):1995;235-240.
89. Nomura S., Yanabu M., Kido H., et al. Antiplatelet autoantibody-related microparticles in patients with idiopathic (autoimmune) thrombocytopenic purpura. Ann. Hematol. 62:(4):1991;103-107.
90. Jy W., Horstman L.L., Arce M., Ahn Y.S. Clinical significance of platelet microparticles in autoimmune thrombocytopenias. J. Lab. Clin. Med. 119:(4):1992;334-345.
91. Hugel B., Socie G., Vu T., et al. Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia. Blood. 93:(10):1999;3451-3456.
92. Ogura H., Kawasaki T., Tanaka H., et al. Activated platelets enhance microparticle formation and platelet-leukocyte interaction in severe trauma and sepsis. J. Trauma. 50:(5):2001;801-809.